Hotel Dieu De France Hospital

This study tests whether empagliflozin, a diabetes drug, can reduce inflammation after a heart stent procedure. About 100 people with stable coronary artery disease scheduled for a stent will take either empagliflozin or a placebo for three days before the procedure. Researchers …